-
|
Reuters –
6:01 AM ET 12/09/2020
West Pharmaceutical Services Inc (WST): * WEST ANNOUNCES FIRST-QUARTER 2021 DIVIDEND, 2021 SHARE REPURCHASE PROGRAM AND PARTICIPATION IN UPCOMING INVESTOR CONFERENCE. * WEST PHARMACEUTICAL SERVICES INC SAYS BOARD AUTHORIZED SHARE REPURCHASE OF UP TO 631,000 SHARES OF COMMON STOCK Source text for Eikon: Further company coverage:
|
-
|
PR Newswire –
6:00 AM ET 12/09/2020
EXTON, Pa., Dec. 9, 2020 West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2021 dividend of $0.17 per share.
|
-
|
Reuters –
6:15 PM ET 11/09/2020
West Pharmaceutical Services Inc (WST): * WEST APPOINTS KIMBERLY BANKS MACKAY AS SENIOR VICE PRESIDENT GENERAL COUNSEL AND CORPORATE SECRETARY Source text for Eikon: Further company coverage:
|
-
|
PR Newswire –
4:30 PM ET 11/09/2020
EXTON, Pa., Nov. 9, 2020 West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, announced it has appointed Kimberly Banks MacKay to serve as Senior Vice President General Counsel and Corporate Secretary, effective December 8, 2020.
|
-
|
Reuters –
7:36 AM ET 10/28/2020
West Pharmaceutical Services Inc (WST): * WEST ANNOUNCES INCREASE TO FOURTH-QUARTER 2020 DIVIDEND. * West Pharmaceutical Services Inc (WST) - APPROVED Q4 DIVIDEND OF $0.17 PER SHARE, A 6.25% INCREASE Source text for Eikon: Further company coverage:
|
-
|
PR Newswire –
6:00 AM ET 10/28/2020
EXTON, Pa., Oct. 28, 2020 West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a fourth-quarter 2020 dividend of $0.17 per share, a 6.25% increase over the $0.16 per share declared for each of the four preceding quarters.
|
-
|
Reuters –
5:40 PM ET 10/22/2020
West Pharmaceutical Services Inc (WST): * WEST PHARMACEUTICAL SERVICES (WST) - ANNOUNCES FDA 510 CLEARANCE & LAUNCH OF VIAL2BAG ADVANCED 20MM ADMIXTURE DEVICE Source text for Eikon: Further company coverage:
|
-
|
PR Newswire –
5:00 PM ET 10/22/2020
EXTON, Pa., Oct. 22, 2020 West Pharmaceutical Services, Inc. , West Pharmaceutical Services, Inc. (WST) is pleased to announce FDA 510 clearance and launch of its Vial2Bag Advanced 20mm Admixture Device.
|
-
|
Reuters –
6:10 AM ET 10/22/2020
West Pharmaceutical Services Inc (WST): * WEST ANNOUNCES THIRD-QUARTER 2020 RESULTS. * SEES FY 2020 ADJUSTED EARNINGS PER SHARE $4.50 TO $4.55. * Q3 ADJUSTED EARNINGS PER SHARE $1.15. * Q3 EARNINGS PER SHARE $1.09. * Q3 EARNINGS PER SHARE ESTIMATE $0.99 -- REFINITIV IBES DATA. * SEES FY 2020 SALES $2.1 BILLION TO $2.11 BILLION. * Q3 SALES $548 MILLION VERSUS REFINITIV IBES ESTIMATE OF $510.1 MILLION.
|
-
|
PR Newswire –
6:00 AM ET 10/22/2020
EXTON, Pa., Oct. 22, 2020 West Pharmaceutical Services, Inc. (WST) today announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance. Third-Quarter 2020 Summary "Adjusted-diluted EPS" and "organic sales growth" are Non-U.S. GAAP measurements. "Third-quarter results were robust across the entire business, led by High-Value Products and Biologics.
|
Page:
|
Today's and Upcoming Events
-
WST to announce Q4 earnings (Unconfirmed)
-
WST ex-Dividend for $0.17 on 01/19/2021
- Announce Date: 12/09/2020
- Record Date: 01/20/2021
- Pay Date: 02/03/2021
Past Events (last 90 days)
-
WST ex-Dividend for $0.17 on 11/09/2020
- Announce Date: 10/28/2020
- Record Date: 11/11/2020
- Pay Date: 11/18/2020
-
WST announced Q3 earnings.
Data provided by Thomson Reuters © 2021
|